VANDA PHARMACEUTICALS INC filings

SEC filings by VANDA PHARMACEUTICALS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-13RENAISSANCE TECHNOLOGIES LLCVanda Pharmaceuticals Inc.3,681,1256.4%EDGAR
SC 13G/A2024-02-13VANGUARD GROUP INCVanda Pharmaceuticals Inc.3,456,0876.0%EDGAR
SC 13G/A2024-02-09DIMENSIONAL FUND ADVISORS LPVanda Pharmaceuticals Inc.1,967,9853.4%EDGAR
SC 13G/A2024-01-23BlackRock Inc.Vanda Pharmaceuticals Inc.8,346,36714.5%EDGAR
SC 13G/A2024-01-22STATE STREET CORPVanda Pharmaceuticals Inc.-2.1%EDGAR
SC 13G/A2023-10-06BlackRock Inc.Vanda Pharmaceuticals Inc.6,759,11711.8%EDGAR
SC 13G/A2023-02-14MACQUARIE GROUP LTDVanda Pharmaceuticals Inc.1,323,5472.3%EDGAR
SC 13G/A2023-02-14Palo Alto Investors LPVanda Pharmaceuticals Inc.1,087,0641.4%EDGAR
SC 13G/A2023-02-13RENAISSANCE TECHNOLOGIES LLCVanda Pharmaceuticals Inc.2,889,4255.1%EDGAR
SC 13G2023-02-10DIMENSIONAL FUND ADVISORS LPVanda Pharmaceuticals Inc.2,853,8325.0%EDGAR
SC 13G/A2023-02-09VANGUARD GROUP INCVanda Pharmaceuticals Inc.3,992,1667.0%EDGAR
SC 13G/A2023-02-07STATE STREET CORPVanda Pharmaceuticals Inc.-6.6%EDGAR
SC 13G/A2023-01-24BlackRock Inc.Vanda Pharmaceuticals Inc.10,326,61418.2%EDGAR
SC 13G/A2022-02-15ARMISTICE CAPITAL, LLCVanda Pharmaceuticals Inc.00.0%EDGAR
SC 13G/A2022-02-14STATE STREET CORPVanda Pharmaceuticals Inc.-6.0%EDGAR
SC 13G/A2022-02-14MACQUARIE GROUP LTDVanda Pharmaceuticals Inc.2,913,4715.2%EDGAR
SC 13G/A2022-02-14Palo Alto Investors LPVanda Pharmaceuticals Inc.2,834,2445.1%EDGAR
SC 13G/A2022-02-11RENAISSANCE TECHNOLOGIES LLCVanda Pharmaceuticals Inc.3,212,2145.8%EDGAR
SC 13G/A2022-02-10VANGUARD GROUP INCVanda Pharmaceuticals Inc.3,876,6847.0%EDGAR
SC 13G/A2022-01-27BlackRock Inc.Vanda Pharmaceuticals Inc.9,825,37517.6%EDGAR